GleamWall
中文EN

SI SHOULDER INNOVATIONS, INC.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1699350 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY54.9%
TTM net income YoY8.3%
TTM EPS YoY102.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin77.8%
Operating margin-54.4%
Net margin-51.7%
FCF margin-66.2%
EBITDA margin-47.9%

Returns

ROE-25.1%
ROA-20.6%
ROIC (approx.)-27.1%
Asset turnover0.40x

Leverage & solvency

Liabilities / assets18.6%
Debt / equity0.13x
Current ratio10.68x
Interest coverage15.44x

Cash quality & payout

Operating cash flow / net income1.05x
Accruals ratio1.0%
Payout ratio—
Capex / revenue12.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$16.19M$17.18M$16.71M$14.42M$11.76M$11.01M$10.13M$8.72M
Cost of revenue$3.49M$3.73M$3.72M$3.36M$2.79M$2.62M$2.34M$1.96M
Gross profit$12.71M$13.44M$12.99M$11.06M$8.96M$8.39M$7.79M$6.77M
R&D expense$3.17M$3.39M$3.75M$3.22M$1.52M$1.41M$1.58M$1.17M
SG&A expense$17.14M$20.09M$18.21M$16.34M$15.08M$12.85M$10.50M$9.14M
Operating income-$7.60M-$10.04M-$8.98M-$8.50M-$7.64M-$5.86M-$4.29M-$3.54M
Interest expense-$574,000-$673,000-$436,000-$591,000$78,000$216,000$367,000$391,000
Pretax income-$7.05M-$10.15M-$8.38M-$7.77M-$8.73M-$19.20M-$4.66M-$3.79M
Income tax$0$0$0$0$0$0$0$0
Net income-$7.05M-$10.15M-$8.38M-$7.77M-$8.73M-$19.20M-$4.66M-$3.79M
EBITDA-$6.48M-$8.93M-$7.92M-$7.59M-$6.87M-$5.22M-$3.70M-$2.99M
EPS (basic)-0.34-0.49-0.41—-0.64-165.53-52.13—
EPS (diluted)-0.34-0.49-0.41—-0.64-165.53-52.13—
Weighted avg. shares (diluted)20.84M20.74M20.65M—13.60M115,96589,438—
Balance sheet
Cash & equivalents$36.42M$24.46M$11.49M$26.87M$54.93M$27.05M$6.37M$6.12M
Short-term investments$55.92M$74.53M$97.05M$97.43M$82.35M$12.58M—$8.92M
Receivables$9.29M$10.87M$10.55M$8.27M$7.08M$6.89M—$5.12M
Inventory$24.38M$22.92M$21.83M$21.59M$19.36M$17.08M—$13.96M
Current assets$131.08M$137.41M$145.78M$157.16M$166.61M$68.91M—$35.12M
PP&E, net$13.77M$14.50M$14.47M$12.53M$10.85M$8.51M—$7.49M
Intangibles$14,000$0$25,000$100,000$175,000$250,000—$400,000
Total assets$145.57M$152.01M$160.36M$169.91M$177.76M$77.83M—$43.08M
Current liabilities$12.28M$12.83M$12.34M$14.20M$15.02M$12.49M—$7.65M
Long-term debt$14.85M$14.81M$14.96M$14.91M$14.85M$14.78M—$14.66M
Total debt$14.85M$14.81M$14.96M$14.91M$14.85M$14.78M—$14.66M
Total liabilities$27.15M$27.68M$27.34M$29.16M$29.93M$29.33M—$23.30M
Shareholders' equity$118.43M$124.33M$133.02M$140.75M$147.83M-$78.20M-$59.31M-$54.70M
Net debt-$21.57M-$9.65M$3.47M-$11.96M-$40.09M-$12.27M—$8.54M
Shares outstanding20.92M20.82M20.70M20.62M20.58M2.84M—83,882
Cash flow statement
Operating cash flow-$6.39M-$7.39M-$12.36M-$8.78M-$8.55M-$4.80M-$6.48M-$3.27M
Capital expenditure$586,000$2.16M$2.73M$2.28M$2.81M$1.47M$843,000$1.04M
Free cash flow-$6.98M-$9.55M-$15.09M-$11.06M-$11.37M-$6.26M-$7.32M-$4.32M
Investing cash flow$18.13M$20.44M-$3.12M-$17.28M-$72.44M$7.19M-$13.07M$3.65M
Financing cash flow$215,000-$84,000$101,000-$2.00M$108.87M$18.29M$19.79M$0
Depreciation & amortization$1.12M$1.11M$1.06M$905,000$768,000$643,000$593,000$544,000
Stock-based compensation$1.02M$1.08M$726,000$381,000$298,000$190,000$127,000$179,000

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.